Company Overview of Q Therapeutics, Inc.
Q Therapeutics, Inc., through its subsidiary, is engaged in developing human cell-based therapies intended to treat degenerative diseases of the brain and spinal cord, the primary components of the central nervous system. It develops Q-Cells that are healthy human glial cells intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, stroke, Huntington’s disease, Parkinson’s disease, and Alzheimer’s disease. The company was formerly known as Q Holdings, Inc. and changed its name to Q Therapeutics, Inc. in December 2012. Q Therapeutics, Inc. is based in Salt Lake City, Utah.
615 Arapeen Drive
Salt Lake City, UT 84108
Key Executives for Q Therapeutics, Inc.
Q Therapeutics, Inc. Key Developments
Similar Private Companies By Industry
|ImmunoGenetix Therapeutics, Inc.||United States|
|Angiorad, L.L.C.||United States|
|Flower Genetics LLC||United States|
|Applied Veterinary Systems||United States|
|Pacific Biotech, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Q Therapeutics, Inc., please visit www.qthera.com. Company data is provided by Capital IQ. Please use this form to report any data issues.